SEMDEXA
Dead / Abandoned — Abandoned — no statement of use filed (as of 06 Feb 2023)
What this means for you
This application is over — abandoned 06 Feb 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88503732
- Mark type
- Stylized text
- Filed
- 08 Jul 2019
- Published for opposition
- 05 Nov 2019
- Abandoned
- 06 Feb 2023
- Attorney of record
- John Paul Oleksiuk
Goods and services
- Class 005 — Pharmaceuticals: Pain relief medication; preparations for the relief of pain; injectable pharmaceutical gels for treatment of back pain, including lumbosacral radicular pain and sciatica; dexamethasone sodium phosphate for medical use for use in the treatment of pain; dexamethasone sodium phosphate gel for medical use
Owner
- Semnur Pharmaceuticals, Inc., Mountain View, CA, US
- Semnur Pharmaceuticals, Inc., Mountain View, CA, US
Prosecution history
- 06 Feb 2023 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 06 Feb 2023 — ABANDONMENT - NO USE STATEMENT FILED
- 25 May 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 24 May 2022 — SOU EXTENSION 5 GRANTED
- 20 May 2022 — SOU EXTENSION 5 FILED
- 24 May 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 20 May 2022 — SOU TEAS EXTENSION RECEIVED
- 21 Dec 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 Dec 2021 — SOU EXTENSION 4 GRANTED
- 17 Dec 2021 — SOU EXTENSION 4 FILED
- 17 Dec 2021 — SOU TEAS EXTENSION RECEIVED
- 22 Jun 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Jun 2021 — SOU EXTENSION 3 GRANTED
- 18 Jun 2021 — SOU EXTENSION 3 FILED
- 18 Jun 2021 — SOU TEAS EXTENSION RECEIVED